Ann: Immuron Aims to Secure FDA Approval for IMM-124E, page-5

  1. 928 Posts.
    lightbulb Created with Sketch. 61
    Really highlights the potential of Travelan. $100M in sales is very possible given that it's the only effective drug that prevents TD, and without any side effects. This company is just absurdly undervalued. I believe the company is worth at least 5X the current market cap alone solely based on the traveler's diarrhea indication.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
6.1¢
Change
-0.002(3.17%)
Mkt cap ! $14.27M
Open High Low Value Volume
6.4¢ 6.4¢ 6.1¢ $7.367K 115.6K

Buyers (Bids)

No. Vol. Price($)
1 50000 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 60163 2
View Market Depth
Last trade - 11.53am 09/07/2025 (20 minute delay) ?
IMC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.